Stocklytics Platform
Asset logo for symbol CTLT
Catalent
CTLT53
$63.48arrow_drop_up0.01%$0.01
Asset logo for symbol CTLT
CTLT53

$63.48

arrow_drop_up0.01%
Key Stats
Open$63.49
Prev. Close$63.48
EPS-2.28
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range63.44
63.49
52 Week Range31.80
63.84
Ratios
EPS-2.28
Fundamentals
Payout Ratio-
Industry average yield2.97%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

CTLT-
US Healthcare Sector-
US Market-
warning

CTLT / Market

CTLT lose to the US Market which returned 1.39% over the last twenty four hours.
warning

CTLT / Healthcare Sector

CTLT lose to the US Healthcare sector which returned 3.18% over the last twenty four hours.

Catalent (CTLT) Statistics

Catalent Inc (CTLT) is a global leader in providing advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The company operates through three segments: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. With a market capitalization of over $15 billion, Catalent has established itself as a major player in the pharmaceutical industry.
When it comes to stock statistics, Catalent Inc (CTLT) has shown impressive performance. The stock has been consistently outperforming the sector, with a year-to-date return of over 30%. The company has also witnessed significant revenue growth, with revenue per share reaching $4.25. This indicates a strong financial position and favorable market conditions for Catalent.
add Catalent  to watchlist

Keep an eye on Catalent

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Catalent (CTLT) stock's performance compared to its sector and the market over the past year?

Over the past year, Catalent (CTLT) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 24.81%, Catalent has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 46.85%, it has fallen short of the market average. This comparison highlights Catalent 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Catalent (CTLT) stock?

The PE ratio for Catalent (CTLT) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Catalent (CTLT) stock?

The Earnings Per Share (EPS) for Catalent (CTLT), calculated on a diluted basis, is -$2.28. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Catalent (CTLT) stock?

The operating margin for Catalent (CTLT) is -6.94%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Catalent (CTLT) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Catalent (CTLT) is $379M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Catalent (CTLT) have?

Catalent (CTLT) has a total debt of $4.95B. The net debt, which accounts for cash and cash equivalents against the total debt, is $4.61B.

Take Your Investments to a Whole New Level